Subscribe

Stay Informed. Stay Ahead.

Subscribe to receive curated updates, expert insights, and practical education—delivered straight to your inbox.

Get timely coverage on new approvals, case-based discussions, conference highlights, and practical tools for everyday practice in community oncology and hematology.

Subscribe
*
Skip to main content
OncUpdates
  • Conferences
    • ASCO
      • Rapid Reactions
    • ASCO GU
    • ASCO GI
    • ASH
    • SABCS
    • ESMO
    • WCLC
  • Videos & Podcasts
    • Challenging Cases
      • Breast Cancer
      • GU Oncology
      • Hematology
      • Lung Cancer
    • New Approvals
      • Breast Cancer
      • GI Oncology
      • GU Oncology
      • Hematology
      • Lung Cancer
    • Tox Check
      • Breast Cancer
      • GI Oncology
      • GU Oncology
      • Hematology
      • Lung Cancer
    • Treatment Algorithms
      • Breast Cancer
      • Dermatology
      • GI Oncology
      • GU Oncology
      • Head and Neck Cancers
      • Hematology
      • Lung Cancer
      • Ovarian Cancer
  • Clinical Insights
    • Head & Neck Cancer
    • GU Oncology
      • Bladder Cancer
      • RCC
    • GI Oncology
      • Gastric/GEJ Cancer
      • Pancreatic Cancer
    • Breast Cancer
      • Early HR+
      • Metastatic HR+
    • Hematology
      • Polycythemia Vera
      • Multiple Myeloma
    • Lung Cancer
      • SCLC
      • NSCLC
  • Resource Centers
    • Cell Therapy
    • Pancreatic Cancer
    • Metastatic Breast Cancer
  • Articles
    • GI Oncology
    • GU Oncology
    • Hematology
    • Lung Cancer
  • Events
  • Conferences
    • ASCO
      • Rapid Reactions
    • ASCO GU
    • ASCO GI
    • ASH
    • SABCS
    • ESMO
    • WCLC
  • Videos & Podcasts
    • Challenging Cases
      • Breast Cancer
      • GU Oncology
      • Hematology
      • Lung Cancer
    • New Approvals
      • Breast Cancer
      • GI Oncology
      • GU Oncology
      • Hematology
      • Lung Cancer
    • Tox Check
      • Breast Cancer
      • GI Oncology
      • GU Oncology
      • Hematology
      • Lung Cancer
    • Treatment Algorithms
      • Breast Cancer
      • Dermatology
      • GI Oncology
      • GU Oncology
      • Head and Neck Cancers
      • Hematology
      • Lung Cancer
      • Ovarian Cancer
  • Clinical Insights
    • Head & Neck Cancer
    • GU Oncology
      • Bladder Cancer
      • RCC
    • GI Oncology
      • Gastric/GEJ Cancer
      • Pancreatic Cancer
    • Breast Cancer
      • Early HR+
      • Metastatic HR+
    • Hematology
      • Polycythemia Vera
      • Multiple Myeloma
    • Lung Cancer
      • SCLC
      • NSCLC
  • Resource Centers
    • Cell Therapy
    • Pancreatic Cancer
    • Metastatic Breast Cancer
  • Articles
    • GI Oncology
    • GU Oncology
    • Hematology
    • Lung Cancer
  • Events

Explore Videos, Articles & More

Breast Cancer

Expert-led videos and podcasts highlighting the latest regulatory approvals in breast cancer, with discussion of emerging therapies, clinical trial data, and their implications for treatment decision-making and practice integration.

Home / Videos & Podcasts / New Approvals / Breast Cancer
T-DXd Plus Pertuzumab and New Data in HER2+ Metastatic Breast Cancer
T-DXd Plus Pertuzumab and New Data in HER2+ Metastatic Breast Cancer

Sara Tolaney, MD, MPH, Rohit Gosain, MD, Rahul Gosain, MD, MBA

OncUpdates

Empowering oncology professionals with The latest insights, breakthroughs, And expert opinions

Quick Links

  • About Us
  • Upcoming Events
  • Follow on X
  • Follow on LinkedIn
  • Follow on YouTube

Legal

  • Terms of Use
  • Privacy Policy
  • Cookie Settings
  • Authors
  • Contact Us

Subscribe to Our Newsletters


Property of SignifyMD LLC, All Rights Reserved 2026 SignifyMD LLC PO Box 512, Brielle, NJ 08730


Oncology Resources | Hematology Support | Community Oncology